Attenua Raises $35M in Series A Financing to Advance Therapy for Chronic Cough

$35M Series A financing led by Omega Funds, with participation from Abingworth, OrbiMed and Redmile Group Michael Kitt, MD, former Chief Medical Officer at Afferent Pharmaceuticals, joins as CEO MOUNTAIN VIEW, Calif., April 30, 2018 -- (Healthcare Sa... Biopharmaceuticals, Venture Capital, Personnel Attenua , Chronic Cough, Cough
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news